SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: VLAD who wrote (10331)7/1/1998 7:52:00 PM
From: BigKNY3  Read Replies (2) | Respond to of 23519
 
VLAD <<I see you are getting a wee bit agitated by the lack of Pfun with your Pfizer investment. I will pretty much agree with all of Colby's replys to your questions (thanks Colby for saving me some time)....BTW, after communicating with my contact at the FDA today I was told that the commission is seriously considering pulling Viagra off the shelves until the safety issues can be resolved including the retinopathy issue>>

VLAD: In fact, I am very pleased with my PFE investment and hope to add more on any dips.

What great inside information from your contact at FDA. Since you consider this contact so reliable, what action did you take based on this information? Short PFE or add to your VVUS portfolio? If you did nothing, I guess even you don't believe your contact. Let's the Board know.

Good investing!

BigKNY3



To: VLAD who wrote (10331)7/1/1998 10:40:00 PM
From: RCMac  Read Replies (1) | Respond to of 23519
 
>>the commission [FDA] is seriously considering pulling Viagra off the shelves until the safety issues can be resolved including the retinopathy issue<< according to your >>contact at the FDA.<<

VLAD, can you expand on what you were told by your "contact at the FDA"? What is supposedly being said, by whom, at what levels in the agency? Any idea when such a decision might be made, or what further evidence might trigger a decision?

--RCM